Industry–Academic Relationship in a New Era of Drug Discovery

Abstract

The pharmaceutical industry is entering a renewed period of productivity as a result of advances in the understanding of human biology, particularly in the areas of genetics and immunology. The relationship between industry and academia needs to evolve to maximize the opportunity. In four areas-target identification, the molecule itself, experimental medicine, and larger-scale clinical testing-there are specific needs for academic partnerships that should be open and transparent and include talent, skills, and career development.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 12 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.